These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 24952056)

  • 1. Cost-effectiveness of contemporary vascular closure devices for the prevention of vascular complications after percutaneous coronary interventions in an all-comers PCI population.
    Kerré S; Kustermans L; Vandendriessche T; Bosmans J; Haine SE; Miljoen H; Vrints CJ; Beutels P; Wouters K; Claeys MJ
    EuroIntervention; 2014 Jun; 10(2):191-7. PubMed ID: 24952056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Costs of transradial percutaneous coronary intervention.
    Amin AP; House JA; Safley DM; Chhatriwalla AK; Giersiefen H; Bremer A; Hamon M; Baklanov DV; Aluko A; Wohns D; Mathias DW; Applegate RA; Cohen DJ; Marso SP
    JACC Cardiovasc Interv; 2013 Aug; 6(8):827-34. PubMed ID: 23871512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of radial access versus femoral access with the use of a vascular closure device for the prevention of vascular complications and mortality after percutaneous coronary intervention.
    Téblick A; Vanderbruggen W; Vandendriessche T; Bosmans J; Haine SEF; Miljoen H; Segers V; Wouters K; Vrints C; Claeys MJ
    Acta Cardiol; 2018 Jun; 73(3):241-247. PubMed ID: 28851255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Same-day discharge after coronary stenting and femoral artery device closure: A randomized study in stable and low-risk acute coronary syndrome patients.
    Clavijo LC; Cortes GA; Jolly A; Tun H; Mehra A; Gaglia MA; Shavelle D; Matthews RV
    Cardiovasc Revasc Med; 2016; 17(3):155-61. PubMed ID: 27157292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bleeding and vascular complications at the femoral access site following percutaneous coronary intervention (PCI): an evaluation of hemostasis strategies.
    Tavris DR; Wang Y; Jacobs S; Gallauresi B; Curtis J; Messenger J; Resnic FS; Fitzgerald S
    J Invasive Cardiol; 2012 Jul; 24(7):328-34. PubMed ID: 22781471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship Between Femoral Vascular Closure Devices and Short-Term Mortality From 271 845 Percutaneous Coronary Intervention Procedures Performed in the United Kingdom Between 2006 and 2011: A Propensity Score-Corrected Analysis From the British Cardiovascular Intervention Society.
    Farooq V; Goedhart D; Ludman P; de Belder MA; Harcombe A; El-Omar M;
    Circ Cardiovasc Interv; 2016 Jun; 9(6):. PubMed ID: 27225421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of collagen-based vascular closure devices in patients with vs. without severe peripheral artery disease.
    Kara K; Kahlert P; Mahabadi AA; Plicht B; Lind AY; Longwitz D; Bollow M; Erbel R
    J Endovasc Ther; 2014 Feb; 21(1):79-84. PubMed ID: 24502487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health Economic Analysis of Access Site Practice in England During Changes in Practice: Insights From the British Cardiovascular Interventional Society.
    Mamas MA; Tosh J; Hulme W; Hoskins N; Bungey G; Ludman P; de Belder M; Kwok CS; Verin N; Kinnaird T; Bennett E; Curzen N; Nolan J; Kontopantelis E
    Circ Cardiovasc Qual Outcomes; 2018 May; 11(5):e004482. PubMed ID: 29743163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Practices and complications of vascular closure devices and manual compression in patients undergoing elective transfemoral coronary procedures.
    Smilowitz NR; Kirtane AJ; Guiry M; Gray WA; Dolcimascolo P; Querijero M; Echeverry C; Kalcheva N; Flores B; Singh VP; Rabbani L; Kodali S; Collins MB; Leon MB; Moses JW; Weisz G
    Am J Cardiol; 2012 Jul; 110(2):177-82. PubMed ID: 22482861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Collagen plug-based vascular closure devices do not decrease vascular and bleeding complications occurring after balloon aortic valvuloplasty.
    Leclercq F; Delseny D; Gervasoni R; Lattuca B; Roubille F; Cayla G; Macia JC
    Arch Cardiovasc Dis; 2015 Apr; 108(4):250-7. PubMed ID: 25754907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of Arterial Closure Devices for Preventing Complications With Percutaneous Coronary Intervention: An Instrumental Variable Analysis.
    Wimmer NJ; Secemsky EA; Mauri L; Roe MT; Saha-Chaudhuri P; Dai D; McCabe JM; Resnic FS; Gurm HS; Yeh RW
    Circ Cardiovasc Interv; 2016 Apr; 9(4):e003464. PubMed ID: 27059685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and efficacy of using vascular closure devices for hemostasis on sheath removal after a transfemoral artery percutaneous coronary intervention.
    Su SF; Chang MY; Wu MS; Liao YC
    Jpn J Nurs Sci; 2019 Apr; 16(2):172-183. PubMed ID: 30044037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association Of Bleeding Avoidance Strategies with age-related bleeding and In-hospital mortality in patients undergoing percutaneous coronary Interventions.
    Khambatta S; Othman H; Seth M; Lalonde T; Rosman HS; Gurm HS; Mehta RH;
    Cardiovasc Revasc Med; 2016 Jun; 17(4):233-40. PubMed ID: 26994504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A propensity analysis of the risk of vascular complications after cardiac catheterization procedures with the use of vascular closure devices.
    Arora N; Matheny ME; Sepke C; Resnic FS
    Am Heart J; 2007 Apr; 153(4):606-11. PubMed ID: 17383300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative safety of vascular closure devices and manual closure among patients having percutaneous coronary intervention.
    Gurm HS; Hosman C; Share D; Moscucci M; Hansen BB;
    Ann Intern Med; 2013 Nov; 159(10):660-6. PubMed ID: 24247671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Costs Associated With Access Site and Same-Day Discharge Among Medicare Beneficiaries Undergoing Percutaneous Coronary Intervention: An Evaluation of the Current Percutaneous Coronary Intervention Care Pathways in the United States.
    Amin AP; Patterson M; House JA; Giersiefen H; Spertus JA; Baklanov DV; Chhatriwalla AK; Safley DM; Cohen DJ; Rao SV; Marso SP
    JACC Cardiovasc Interv; 2017 Feb; 10(4):342-351. PubMed ID: 28231901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Full conversion from transfemoral to transradial approach for percutaneous coronary interventions results in a similar success rate and a rapid reduction of in-hospital cardiac and vascular major events.
    Dangoisse V; Guédès A; Gabriel L; Jamart J; Chenu P; Marchandise B; Schroeder E
    EuroIntervention; 2013 Jul; 9(3):345-52. PubMed ID: 23872649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel, minimally invasive access technique versus standard 18-gauge needle set for femoral access.
    Ben-Dor I; Maluenda G; Mahmoudi M; Torguson R; Xue Z; Bernardo N; Lindsay J; Satler LF; Pichard AD; Waksman R
    Catheter Cardiovasc Interv; 2012 Jun; 79(7):1180-5. PubMed ID: 22334384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transfemoral approach with systematic use of FemoSeal™ closure device compared to transradial approach in primary angioplasty.
    Alonzo A; Rigattieri S; Giovannelli F; Di Russo C; Sciahbasi A; Berni A; Volpe M
    Catheter Cardiovasc Interv; 2016 Apr; 87(5):849-54. PubMed ID: 26104978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost effectiveness of radial access for diagnostic cardiac catheterization and coronary intervention.
    Applegate R; Sacrinty M; Schafer P; Smith J; Gandhi S; Kutcher M; Santos R; Cecile A; Little W
    Catheter Cardiovasc Interv; 2013 Oct; 82(4):E375-84. PubMed ID: 23074085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.